These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 38391002

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
    Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL.
    J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
    [Abstract] [Full Text] [Related]

  • 3. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H, Cambridge G, Bourke L, Sen D, Radziszewska A, Leandro M, Ioannou Y.
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Limitations in the classification of childhood-onset rheumatoid arthritis.
    Ferrell EG, Ponder LA, Minor LS, Angeles-Han ST, Kennedy CW, Rouster-Stevens KA, Rohani-Pichavant M, Vogler LB, Prahalad S.
    J Rheumatol; 2014 Mar; 41(3):547-53. PubMed ID: 24488421
    [Abstract] [Full Text] [Related]

  • 8. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis.
    van Rossum M, van Soesbergen R, de Kort S, ten Cate R, Zwinderman AH, de Jong B, Dijkmans B, van Venrooij WJ.
    J Rheumatol; 2003 Apr; 30(4):825-8. PubMed ID: 12672206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Profiling anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Tebo AE, Jaskowski T, Davis KW, Whiting A, Clifford B, Zeft A, McNally B, Hill HR, Bohnsack J, Prahalad S.
    Pediatr Rheumatol Online J; 2012 Aug 29; 10(1):29. PubMed ID: 22931121
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis.
    Hromadnikova I, Stechova K, Pavla V, Hridelova D, Houbova B, Voslarova S, Nekvasilova H, Vavrinec J.
    Autoimmunity; 2002 Sep 29; 35(6):397-401. PubMed ID: 12568120
    [Abstract] [Full Text] [Related]

  • 20. 14-3-3η Protein as a Potential Biomarker in Juvenile Idiopathic Arthritis.
    Dalrymple A, Tuttle P, Feller L, Zhukov O, Lagier R, Popov J, Naides S, Moore T.
    Pediatr Rep; 2021 Jan 25; 13(1):65-71. PubMed ID: 33504004
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.